Gianfranco Caselli

Via Valosa Di Sopra 7
Monza, 20052, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Ferulated Poly(vinyl alcohol) based hydrogels.

Ferulated Poly(vinyl alcohol) based hydrogels.

Journal: Heliyon

Published: July 24, 2023

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19.

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 21, 2022

Modulation of NMDA receptor activity by CR4056, an imidazoline-2 receptor ligand with analgesic properties.

Modulation of NMDA receptor activity by CR4056, an imidazoline-2 receptor ligand with analgesic properties.

Journal: Frontiers in pain research (Lausanne, Switzerland)

Published: July 25, 2022

I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice.

I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice.

Journal: International journal of molecular sciences

Published: May 30, 2022

Toxicity and Local Tolerance of COVID- eVax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation.

Toxicity and Local Tolerance of COVID- eVax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation.

Journal: Toxicologic pathology

Published: September 08, 2021

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 01, 2021

CR13626: a novel oral brain penetrant tyrosine kinase inhibitor that reduces tumor growth and prolongs survival in a mouse model of glioblastoma.

CR13626: a novel oral brain penetrant tyrosine kinase inhibitor that reduces tumor growth and prolongs survival in a mouse model of glioblastoma.

Journal: American journal of cancer research

Published: May 05, 2021

Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models.

Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models.

Journal: British journal of pharmacology

Published: April 18, 2019

CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons.

CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons.

Journal: British journal of pharmacology

Published: July 25, 2018

Development of subnanomolar-affinity serotonin 5-HT4 receptor ligands based on quinoline structures.

Development of subnanomolar-affinity serotonin 5-HT4 receptor ligands based on quinoline structures.

Journal: MedChemComm

Published: May 04, 2018

Poly-histidine grafting leading to fishbone-like architectures.

Poly-histidine grafting leading to fishbone-like architectures.

Journal: RSC advances

Published: January 11, 2018

Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.

Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.

Journal: Arthritis research & therapy

Published: November 21, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026